IMB-1003

N/A

Report date: 2023/10/23 17:52:53

Base Information

Drug NameIMB-1003
Drug Alias NameIMB-1003
ClassificationBiologics > Protein drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicCrohn Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIMIDomics Inc
China Registration ClassN/A

Develop Information

Active CompaniesIMIDomics Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, SystemicCrohn Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A